AAAAAA
Results:
1-7
|
Results: 7
Authors:
Ebid, AHIM
Shelton, MJ
Adams, JM
Cordaro, JA
Gugino, LJ
Maliszewski, M
Colomaio, R
Hewitt, RG
Morse, GD
Citation: Ahim. Ebid et al., Menstrual cycle and zidovudine pharmacokinetics in HIV-infected women, CLIN DRUG I, 21(10), 2001, pp. 715-726
Authors:
Hardy, H
Esch, LD
Morse, GD
Citation: H. Hardy et al., Glucose disorders associated with HIV and its drug therapy, ANN PHARMAC, 35(3), 2001, pp. 343-351
Authors:
Pelham, WE
Gnagy, EM
Burrows-Maclean, L
Williams, A
Fabiano, GA
Morrisey, SM
Chronis, AM
Forehand, GL
Nguyen, CA
Hoffman, MT
Lock, TM
Fielbelkorn, K
Coles, EK
Panahon, CJ
Steiner, RL
Meichenbaum, DL
Onyango, AN
Morse, GD
Citation: We. Pelham et al., Once-a-day concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings, PEDIATRICS, 107(6), 2001, pp. NIL_104-NIL_118
Authors:
Shelton, MJ
Akbari, B
Hewitt, RG
Adams, JM
Morse, GD
Citation: Mj. Shelton et al., Eradication of Helicobacter pylori is associated with increased exposure to delavirdine in hypochlorhydric HIV-positive patients, J ACQ IMM D, 24(1), 2000, pp. 79-82
Authors:
Morse, GD
Reichman, RC
Fischl, MA
Para, M
Leedom, J
Powderly, W
Demeter, LM
Resnick, L
Bassiakos, Y
Timpone, J
Cox, S
Batts, D
Citation: Gd. Morse et al., Concentration-targeted phase I trials of atevirdine mesylate in patients with HIV infection: dosage requirements and pharmacokinetic studies, ANTIVIR RES, 45(1), 2000, pp. 47-58
Authors:
Smith, PF
Morse, GD
Citation: Pf. Smith et Gd. Morse, Accuracy of measured vancomycin serum concentrations in patients with end-stage renal disease, ANN PHARMAC, 33(12), 1999, pp. 1329-1335
Authors:
Herman, RA
Noormohamed, S
Hirankarn, S
Shelton, MJ
Huang, E
Morse, GD
Hewitt, RG
Stapleton, JT
Citation: Ra. Herman et al., Comparison of a neural network approach with five traditional methods for predicting creatinine clearance in patients with human immunodeficiency virus infection, PHARMACOTHE, 19(6), 1999, pp. 734-740
Risultati:
1-7
|